Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Journal of Clinical Medicine|January 20, 2021
The Impact of Binge Drinking on Mortality and Liver Disease in the Swiss HIV Cohort StudyBernard Surial, Nicolas Bertholet, Jean-Bernard Daeppen, et al.
Open Forum Infectious Diseases|September 19, 2024
Gender Disparities in Statin Prescriptions in People With HIV With Low/Moderate to High Cardiovascular RiskIrene A Abela, Frédérique Chammartin, Alain Amstutz, et al.
Journal of Hepatology|January 23, 2023
External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfectionBernard Surial, Adrià Ramírez Mena, Marie Roumet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 12, 2024
Weight, Anthropometric and Metabolic Changes After Discontinuing Antiretroviral Therapy Containing Tenofovir Alafenamide in People With HIVJosé Damas, Aline Munting, Jacques Fellay, et al.
Transplantation|April 7, 2022
Infection Risk in the First Year After ABO-incompatible Kidney Transplantation: A Nationwide Prospective Cohort StudyCédric Hirzel, Lea Projer, Andrew Atkinson, et al.
Pharmaceutics|August 26, 2022
Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in SwitzerlandPaul Thoueille, Susana Alves Saldanha, Fabian Schaller, et al.
Frontiers in Pharmacology|December 2, 2024
Population pharmacokinetics of rilpivirine following oral administration and long-acting intramuscular injection in real-world people with HIVPaul Thoueille, Susana Alves Saldanha, Fabian Schaller, et al.
Clinical Pharmacology and Therapeutics|March 23, 2024
Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long-Acting Intramuscular Injection in Real-World People with HIVPaul Thoueille, Susana Alves Saldanha, Fabian Schaller, et al.
The Journal of Infectious Diseases|August 26, 2025
Untargeted Metabolite Profile Associations with Body Mass Index, Waist-Hip Ratio, and Antiretroviral Therapy in >1300 People with HIV: the Swiss HIV Cohort StudyMarco Labarile, Isabella C Schoepf, Chloé Pasin, et al.
Swiss Medical Weekly|June 27, 2022
Changes in mental and sexual health among MSM using HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: longitudinal analysis of the SwissPrEPared cohort studyBabette L Winter, Frédérique Hovaguimian, Roger D Kouyos, et al.
Pageof 5